Literature DB >> 16815352

Development of an ELISA for myeloperoxidase on microplate: normal reference values and effect of temperature on specimen preparation.

Pi-Yueh Chang1, Tsu-Lan Wu, Chung-Chih Hung, Kuo-Chien Tsao, Chien-Feng Sun, Lily L Wu, James T Wu.   

Abstract

BACKGROUND: Myeloperoxidase (MPO), a leukocyte enzyme, is implicated in both the pathogenesis and the progression of atherosclerosis.
METHODS: We developed a sandwich ELISA on microplate using commercial antibodies for the measurement of plasma MPO.
RESULTS: The in-house ELISA has a sensitivity of 15 ng/ml. Both within-day and between-day imprecision were <10%. The in-house assay was well correlated with the commercial kit from Oxis (gamma=0.96). We have established normal reference range for MPO for apparently healthy Chinese. No statistical difference was found between males and females and the various age groups. Because the coating antibodies used by two different kits are different in their affinities for MPO, the analysis by the in-house ELISA that was approximately three times that of the Oxis kit when testing the same specimens. We found that it is necessary to keep the heparinized whole blood on ice before centrifugation in order to prevent further release of MPO from the leukocytes at room temperature. For the same reason, serum is not recommended for MPO measurement. We also found that either pooled human plasma or serum containing MPO can be used as calibrators.
CONCLUSIONS: We believe that this ELISA for MPO is useful to assess risk for inflammation, oxidative stress, nitrosative stress, and for predicting cardiac events.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815352     DOI: 10.1016/j.cca.2006.05.030

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease.

Authors:  Monisha Dhiman; Jose Guillermo Estrada-Franco; Jasmine M Pando; Francisco J Ramirez-Aguilar; Heidi Spratt; Sara Vazquez-Corzo; Gladys Perez-Molina; Rosa Gallegos-Sandoval; Roberto Moreno; Nisha Jain Garg
Journal:  Clin Vaccine Immunol       Date:  2009-03-18

2.  Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones.

Authors:  Kuo-Chien Tsao; Tsu-Lan Wu; Pi-Yueh Chang; Chien-Feng Sun; Lily L Wu; James T Wu
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

3.  A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma.

Authors:  Reece J Goiffon; Sara C Martinez; David Piwnica-Worms
Journal:  Nat Commun       Date:  2015-02-10       Impact factor: 14.919

4.  Airway symptoms and biological markers in nasal lavage fluid in subjects exposed to metalworking fluids.

Authors:  Louise Fornander; Pål Graff; Karin Wåhlén; Kjell Ydreborg; Ulf Flodin; Per Leanderson; Mats Lindahl; Bijar Ghafouri
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 5.  The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.

Authors:  Nathaniel Teng; Ghassan J Maghzal; Jihan Talib; Imran Rashid; Antony K Lau; Roland Stocker
Journal:  Redox Rep       Date:  2016-11-25       Impact factor: 4.412

6.  Optimization of Enzyme Essays to Enhance Reliability of Activity Measurements in Leukocyte Lysates for the Diagnosis of Metachromatic Leukodystrophy and Gangliosidoses.

Authors:  Sebastian Strobel; Naomi Hesse; Vidiyaah Santhanakumaran; Samuel Groeschel; Gernot Bruchelt; Ingeborg Krägeloh-Mann; Judith Böhringer
Journal:  Cells       Date:  2020-11-28       Impact factor: 6.600

7.  Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease.

Authors:  Siew Wai Fong; Ling Ling Few; Wei Cun See Too; Boon Yin Khoo; Nik Nor Izah Nik Ibrahim; Shaiful Azmi Yahaya; Zurkurnai Yusof; Rosli Mohd Ali; Abdul Rashid Abdul Rahman; Get Bee Yvonne-Tee
Journal:  BMC Res Notes       Date:  2015-11-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.